1. P425 Real-world evidence on effectiveness and safety of vedolizumab therapy for inflammatory bowel disease in Taiwan: Results from the TSIBD registry (VIOLET Study). (27th May 2021) Authors: Wei, S C; Lin, W C; Chang, C H; Tu, C H; Feng, I C; Shieh, M J; Chung, C S; Yen, H H; Chou, J W; Tai, W C; Wong, J M; Liu, Y H; Huang, T Y; Chuang, C H; Tsai, T J; Chiang, F F; Lu, C Y; Hsu, W H; Yu, F J; Chao, T H Journal: Journal of Crohn's and colitis Issue: Volume 15(2021)Supplement 1 Page Start: S428 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗